Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Prime Medicine Inc (NASDAQ: PRME) closed at $4.51 in the last session, down -1.74% from day before closing price of $4.59. In other words, the price has decreased by -$1.74 from its previous closing price. On the day, 0.93 million shares were traded. PRME stock price reached its highest trading level at $4.68 during the session, while it also had its lowest trading level at $4.34.
Ratios:
We take a closer look at PRME’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.53 and its Current Ratio is at 2.53. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.03.
On April 03, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $12.
Stifel Downgraded its Buy to Hold on January 16, 2024, whereas the target price for the stock was revised from $18 to $9.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 15 ’24 when ARCH Venture Partners XII, LLC bought 3,200,000 shares for $6.25 per share. The transaction valued at 20,000,000 led to the insider holds 3,200,000 shares of the business.
ARCH Venture Partners X, LLC bought 3,200,000 shares of PRME for $20,000,000 on Feb 15 ’24. The 10% Owner now owns 3,200,000 shares after completing the transaction at $6.25 per share. On Feb 15 ’24, another insider, NELSEN ROBERT, who serves as the Director of the company, bought 3,200,000 shares for $6.25 each. As a result, the insider paid 20,000,000 and bolstered with 3,200,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRME now has a Market Capitalization of 540924928 and an Enterprise Value of 411534656.
Stock Price History:
Over the past 52 weeks, PRME has reached a high of $17.20, while it has fallen to a 52-week low of $4.56. The 50-Day Moving Average of the stock is -36.92%, while the 200-Day Moving Average is calculated to be -50.77%.
Shares Statistics:
According to the various share statistics, PRME traded on average about 698.80K shares per day over the past 3-months and 640700 shares per day over the past 10 days. A total of 97.38M shares are outstanding, with a floating share count of 49.77M. Insiders hold about 58.50% of the company’s shares, while institutions hold 27.57% stake in the company. Shares short for PRME as of 1711584000 were 9923829 with a Short Ratio of 14.20, compared to 1709164800 on 9222470. Therefore, it implies a Short% of Shares Outstanding of 9923829 and a Short% of Float of 20.02.
Earnings Estimates
A detailed examination of Prime Medicine Inc (PRME) is currently in progress, with PRME analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $34.07, with high estimates of $18.43 and low estimates of $4.51.
